Skip to NavigationSkip to content

ABPI Chief Executive Mike Thompson to retire by the end of 2019

Published on 05/07/19 at 10:57am

The Association of the British Pharmaceutical Industry (ABPI) has announced that its Chief Executive Mike Thompson is to retire from his role by the end of this year.

His decision to leave the association marks the end of a three-year run beginning in March 2016, when stepped in to take up the mantle from Alison Clough, who had served as the acting Chief Executive for much of 2015.

Prior to this move, he served at major UK pharma firm GlaxoSmithKline as Seniuor Vice President of Global Commercial Strategy, the final role of a tenure last 20 years. During that time, he also serve as Commercial Strategy Head for Europe and a decade shouldering a range of senior sales and marketing positions in the UK Operating Company.

“This has been an extraordinary period to have had led the ABPI. Whilst the media has focussed on the challenges the country has faced, we can be proud of how we’ve used the dynamic to bring about positive change,” commented Thompson. “There is a lot more to say, particularly about the great people I’ve loved working with, but there will be time for that at the end of the year. I am making this announcement now so that there can be an open, and timely process to find my successor.”

The association announced that it would be recruiting for a replacement.  

Matt Fellows

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches